PSUSA/00001317/202503
Submitted by Anonymous (not verified) on 5 November 2025 - 16:22
PSUSA/00001317/202503
PSUSA/00001466/202503
Submitted by Anonymous (not verified) on 5 November 2025 - 16:05
PSUSA/00001466/202503
Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Date of authorisation: 20/06/2002, Revision: 48, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2025 - 15:50
Human medicines European public assessment report (EPAR): Pegasys, peginterferon alfa-2a, Date of authorisation: 20/06/2002, Revision: 48, Status: Authorised
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2025 - 15:45
Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Revision: 3, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Portela, relfovetmab, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2025 - 14:54
Veterinary medicines European public assessment report (EPAR): Portela, relfovetmab, Status: Authorised
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2025 - 14:45
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 6, Status: Authorised
Human medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 12, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2025 - 14:40
Human medicines European public assessment report (EPAR): Mektovi, binimetinib, Date of authorisation: 20/09/2018, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 17, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2025 - 14:35
Human medicines European public assessment report (EPAR): Braftovi, encorafenib, Date of authorisation: 19/09/2018, Revision: 17, Status: Authorised
On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services
Submitted by Anonymous (not verified) on 5 November 2025 - 14:00
On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services
Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 27, Status: Authorised
Submitted by Anonymous (not verified) on 5 November 2025 - 13:55
Human medicines European public assessment report (EPAR): Ivemend, fosaprepitant, Date of authorisation: 11/01/2008, Revision: 27, Status: Authorised